Stableford Capital II LLC cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 29.7% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,976 shares of the healthcare conglomerate's stock after selling 1,256 shares during the quarter. Stableford Capital II LLC's holdings in UnitedHealth Group were worth $928,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also bought and sold shares of the stock. Vanguard Group Inc. raised its holdings in UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after buying an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP raised its holdings in UnitedHealth Group by 10.6% during the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock worth $13,537,859,000 after buying an additional 2,486,839 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in UnitedHealth Group by 2.5% during the first quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate's stock worth $4,257,131,000 after buying an additional 196,696 shares during the last quarter. Nuveen LLC acquired a new position in UnitedHealth Group during the first quarter worth $3,846,764,000. Finally, Charles Schwab Investment Management Inc. raised its holdings in UnitedHealth Group by 13.6% during the first quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate's stock worth $3,702,736,000 after buying an additional 847,054 shares during the last quarter. 87.86% of the stock is owned by institutional investors.
UnitedHealth Group Price Performance
UNH opened at $360.77 on Thursday. The company has a market capitalization of $326.73 billion, a price-to-earnings ratio of 15.63, a PEG ratio of 2.33 and a beta of 0.47. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a 50-day moving average price of $325.04 and a 200-day moving average price of $347.17. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.UnitedHealth Group's revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group's dividend payout ratio (DPR) is presently 38.30%.
Analysts Set New Price Targets
Several analysts have recently commented on UNH shares. Morgan Stanley increased their target price on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an "overweight" rating in a report on Friday, September 12th. KeyCorp increased their target price on shares of UnitedHealth Group from $350.00 to $400.00 and gave the company an "overweight" rating in a report on Wednesday, October 8th. UBS Group reiterated a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Oppenheimer decreased their price objective on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a report on Wednesday, July 30th. Finally, Weiss Ratings restated a "sell (d+)" rating on shares of UnitedHealth Group in a report on Wednesday, October 8th. Seventeen analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $384.09.
Check Out Our Latest Analysis on UNH
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.